Sales of birth control pills in Romania are similar to those of other countries in the region, the market reaching 12 million euros last year, over a 10% increase. “The Romanian market of oral contraceptives is doing well compared with that of other countries formerly under communist control. If you compare it to Western states, however, Romania witnesses a high abortion rate,” Catalin Radu, general manager of Schering Romania said on Wednesday. The company has a share of over 50% of the Romanian oral contraceptive market, estimated at 12 million euros by Schering representatives. Last year Schering launched an oral contraceptive called Yasmin, one of the company’s best selling products on both international and domestic markets. This product’s sales amounted to approximately 0.65 million euros in 2005. “Yasmin has performed extremely well, and our sales have reached at approximately 1.8 million euros this year,” said Catalin Radu.